(February 19, 2016, 1:36 PM EST) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Feb. 17 said it will hear arguments at its next hearing session about the centralization of federal lawsuits against Genentech Inc. for allegedly providing 11 cancer centers with Herceptin vials that contained too little of the breast cancer drug or had the wrong instructions for the drug (In Re: Genentech Herceptin Litigation, MDL Docket No. 2700, JPML)....